157 related articles for article (PubMed ID: 37325329)
1. Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019.
Moradi S; Parsaei A; Saeedi Moghaddam S; Aryannejad A; Azadnajafabad S; Rezaei N; Mashinchi B; Esfahani Z; Shobeiri P; Rezaei N; ; Naghavi M; Larijani B; Farzadfar F
Front Public Health; 2023; 11():1149719. PubMed ID: 37325329
[TBL] [Abstract][Full Text] [Related]
2. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Risk Factors Collaborators
Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
[TBL] [Abstract][Full Text] [Related]
3. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
[TBL] [Abstract][Full Text] [Related]
4. National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019.
Aryannejad A; Saeedi Moghaddam S; Mashinchi B; Tabary M; Rezaei N; Shahin S; Rezaei N; ; Naghavi M; Larijani B; Farzadfar F
Breast Cancer Res; 2023 Apr; 25(1):47. PubMed ID: 37101247
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the lead exposure attributed burden in Iran from 1990 to 2019 through the lens of the Global Burden of Disease study 2019.
Karimi H; Mahdavi S; Moghaddam SS; Abbasi-Kangevari M; Soleimani Z; Esfahani Z; Masinaei M; Fateh SM; Golestani A; Dilmaghani-Marand A; Kompani F; Rezaei N; Ghasemi E; Larijani B; Farzadfar F
Sci Rep; 2024 Apr; 14(1):8688. PubMed ID: 38622232
[TBL] [Abstract][Full Text] [Related]
6. A 30-year trend of ischemic heart disease burden in a developing country; a systematic analysis of the global burden of disease study 2019 in Iran.
Koolaji S; Sharifnejad Tehrani Y; Azadnajafabad S; Saeedi Moghaddam S; Shahin S; Ghamari A; Ahmadi N; Rezaei N; Keykhaei M; Tavolinejad H; Ghamari SH; Abbasi-Kangevari M; Rezaei N; Larijani B; Farzadfar F
Int J Cardiol; 2023 May; 379():127-133. PubMed ID: 36898585
[TBL] [Abstract][Full Text] [Related]
7. National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019.
Heidari-Foroozan M; Aryan A; Esfahani Z; Shahrbaf MA; Moghaddam SS; Keykhaei M; Ghasemi E; Rashidi MM; Rezaei N; Ghamari SH; Abbasi-Kangevari M; Fateh SM; Farzi Y; Rezaei N; Larijani B
Respir Res; 2023 Mar; 24(1):74. PubMed ID: 36906596
[TBL] [Abstract][Full Text] [Related]
8. Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.
Sepanlou SG; Parsaeian M; Krohn KJ; Afshin A; Farzadfar F; Roshandel G; Karimkhani C; Bazargan-Hejazi S; Kiadaliri AA; Ahmadieh H; Djalalinia S; Ebrahimi H; Eshrati B; Esteghamati AR; Farvid MS; Fereshtehnejad SM; Hafezi-Nejad N; Hassanvand MS; Heydarpour P; Islami F; Karimi SM; Katibeh M; Khosravi A; Khubchandani J; Mahdavi M; Pishgar F; Qorbani M; Rahimi-Movaghar V; Safi S; Sahraian MA; Shahraz S; Sheikhbahaei S; Mohammadi A; Mokdad AH; Vos T; Murray CJL; Moradi-Lakeh M; Naghavi M; Malekzadeh R
Arch Iran Med; 2017 Jul; 20(7):403-418. PubMed ID: 28745902
[TBL] [Abstract][Full Text] [Related]
9. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Gómez-Dantés H; Fullman N; Lamadrid-Figueroa H; Cahuana-Hurtado L; Darney B; Avila-Burgos L; Correa-Rotter R; Rivera JA; Barquera S; González-Pier E; Aburto-Soto T; de Castro EF; Barrientos-Gutiérrez T; Basto-Abreu AC; Batis C; Borges G; Campos-Nonato I; Campuzano-Rincón JC; de Jesús Cantoral-Preciado A; Contreras-Manzano AG; Cuevas-Nasu L; de la Cruz-Gongora VV; Diaz-Ortega JL; de Lourdes García-García M; Garcia-Guerra A; de Cossío TG; González-Castell LD; Heredia-Pi I; Hijar-Medina MC; Jauregui A; Jimenez-Corona A; Lopez-Olmedo N; Magis-Rodríguez C; Medina-Garcia C; Medina-Mora ME; Mejia-Rodriguez F; Montañez JC; Montero P; Montoya A; Moreno-Banda GL; Pedroza-Tobías A; Pérez-Padilla R; Quezada AD; Richardson-López-Collada VL; Riojas-Rodríguez H; Ríos Blancas MJ; Razo-Garcia C; Mendoza MP; Sánchez-Pimienta TG; Sánchez-Romero LM; Schilmann A; Servan-Mori E; Shamah-Levy T; Téllez-Rojo MM; Texcalac-Sangrador JL; Wang H; Vos T; Forouzanfar MH; Naghavi M; Lopez AD; Murray CJ; Lozano R
Lancet; 2016 Nov; 388(10058):2386-2402. PubMed ID: 27720260
[TBL] [Abstract][Full Text] [Related]
10. The state of health in Indonesia's provinces, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Indonesia Subnational Collaborators
Lancet Glob Health; 2022 Nov; 10(11):e1632-e1645. PubMed ID: 36240829
[TBL] [Abstract][Full Text] [Related]
11. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Iran Collaborators
Lancet; 2022 Apr; 399(10335):1625-1645. PubMed ID: 35397236
[TBL] [Abstract][Full Text] [Related]
12. Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017.
Shahrezaee M; Keshtkari S; Moradi-Lakeh M; Abbasifard M; Alipour V; Amini S; Arabloo J; Arzani A; Bakhshaei M; Barzegar A; Bijani A; Dianatinasab M; Eskandarieh S; Gheshlagh RG; Ghashghaee A; Heidari-Soureshjani R; Irvani SSN; Lahimchi A; Maleki S; Manafi N; Manafi A; Mansournia MA; Mohammadian-Hafshejani A; Bandpei MAM; Moradzadeh R; Naderi M; Pakshir K; Rafiei A; Rashedi V; Rezaei N; Rezapour A; Sahraian MA; Shahabi S; Shamsi M; Soheili A; Soroush A; Zamani M; Mohajer B; Farzadfar F
Arch Osteoporos; 2020 Jul; 15(1):103. PubMed ID: 32651719
[TBL] [Abstract][Full Text] [Related]
13. The burden of Neglected Tropical Diseases in Brazil, 1990-2016: A subnational analysis from the Global Burden of Disease Study 2016.
Martins-Melo FR; Carneiro M; Ramos AN; Heukelbach J; Ribeiro ALP; Werneck GL
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006559. PubMed ID: 29864133
[TBL] [Abstract][Full Text] [Related]
14. Estimating the burden of diseases attributable to lead exposure in the North Africa and Middle East region, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.
Rezaee M; Esfahani Z; Nejadghaderi SA; Abbasi-Kangevari M; Saeedi Moghaddam S; Ghanbari A; Ghamari A; Golestani A; Foroutan Mehr E; Kazemi A; Haghshenas R; Moradi M; Kompani F; Rezaei N; Larijani B
Environ Health; 2022 Oct; 21(1):105. PubMed ID: 36309664
[TBL] [Abstract][Full Text] [Related]
15. Global burden of cardiovascular disease attributable to metabolic risk factors, 1990-2019: an analysis of observational data from a 2019 Global Burden of Disease study.
Wu S; Xu W; Guan C; Lv M; Jiang S; Jinhua Z
BMJ Open; 2023 May; 13(5):e069397. PubMed ID: 37173115
[TBL] [Abstract][Full Text] [Related]
16. National and subnational mortality and disability-adjusted life years (DALYs) attributable to 17 occupational risk factors in Iran, 1990-2015.
Abtahi M; Koolivand A; Dobaradaran S; Yaghmaeian K; Khaloo SS; Jorfi S; Keshmiri S; Nafez AH; Saeedi R
Environ Res; 2018 Aug; 165():158-175. PubMed ID: 29705621
[TBL] [Abstract][Full Text] [Related]
17. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Mental Disorders Collaborators
Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
[TBL] [Abstract][Full Text] [Related]
18. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019.
Liang R; Feng X; Shi D; Yang M; Yu L; Liu W; Zhou M; Wang X; Qiu W; Fan L; Wang B; Chen W
Diabetes Metab Res Rev; 2022 Nov; 38(8):e3572. PubMed ID: 36001650
[TBL] [Abstract][Full Text] [Related]
19. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 DALYs and HALE Collaborators
Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
[TBL] [Abstract][Full Text] [Related]
20. National and subnational burden of brain and central nervous system cancers in Iran, 1990-2019: Results from the global burden of disease study 2019.
Mahdavi M; Moghaddam SS; Abbasi-Kangevari M; Mohammadi E; Shobeiri P; Sharifi G; Jafari A; Rezaei N; Ebrahimi N; Rezaei N; Ghamari SH; Malekpour MR; Khalili M; Larijani B; Kompani F
Cancer Med; 2023 Apr; 12(7):8614-8628. PubMed ID: 36622061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
